Oramed Pharmaceuticals

ORMPNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$178.869 M

$4.30 +0.00%

Close of 7 Aug 2026

Revenue

$2.00M

#3439 by revenue

Earnings

$75.3K

#2460 by earnings

Shares outstanding

40,926,081

Latest filing cover page

P/E ratio

2374.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#273Lifecore Biomedical, Inc. DeLFCR$189.6M
#274Corbus PharmaceuticalsCRBP$188.4M
#275Oramed PharmaceuticalsORMP$178.9M
#276Journey MedicalDERM$177.0M
#277Aardvark TherapeuticsAARD$172.9M

Where these numbers come from

Share counts and financials for Oramed Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.